Analystreport

BioMarin Pharmaceutical (BMRN) had its price target raised by Sanford C. Bernstein from $90.00 to $94.00. They now have an "outperform" rating on the stock.

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com